COMMUNIQUÉS West-GlobeNewswire

Aeroflow Health Announces Lactation Care Services are Now Available to Blue Cross Blue Shield Patients Across the Country
06/06/2024
Aeroflow continues to expand access to postpartum care for new mothers with in-network lactation resources for BCBS patients at little to no additional cost ASHEVILLE, N.C., June 06, 2024 (GLOBE NEWSWIRE) -- Aeroflow [...]
Tiziana Life Sciences Announces Six-Month Qualitative Improvement in Neuroimaging in 80% of Multiple Sclerosis Patients Receiving Intranasal Foralumab
06/06/2024
Qualitative improvements in PET imaging seen in 80% of non-active Secondary Progressive Multiple Sclerosis (na-SPMS) Expanded Access patients receiving intranasal foralumab for at least 6-months. FDA Allowance for an [...]
Updated Time: Agios to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 at 8:40 am ET
06/06/2024
CAMBRIDGE, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced that the time of [...]
Safety Shot Partners with Capital Drugs To Launch World’s First Beverage To Reduce Blood Alcohol Content in 300 Pharmacies Across the Country
06/06/2024
The First of its Kind Vitamin-Packed, Wellness Beverage Brand Continues to Amplify its In-Store Availability Nationwide JUPITER, FL, June 06, 2024 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (the “Company), [...]
Ipsen appoints Josep Catllà as EVP, Chief Corporate Affairs Officer
06/06/2024
PARIS, FRANCE, 06 June 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, announced today the appointment of Josep Catllà as EVP, Chief Corporate Affairs Officer, effective [...]
Ipsen nomme Josep Catllà, en qualité de Vice-Président Exécutif, Chief Corporate Affairs Officer
06/06/2024
PARIS, FRANCE, 06 juin 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique mondial de spécialité, annonce aujourd’hui la nomination de Josep Catllà en tant que Vice-Président Exécutif, Chief Corporate [...]
Scientific Journal Reports Findings that Show LIXTE’s Lead Clinical Compound, LB-100, Increases Recognition of Colon Cancer Cells by the Immune System
06/06/2024
LB-100 Generates Neo-Antigens in Cancer Cells that are Presented to the Immune System by Disrupting the Process of RNA Splicing PASADENA, CA, June 06, 2024 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc . (“LIXTE [...]
SeaStar Medical Announces 25-for-1 Reverse Stock Split
06/06/2024
DENVER, June 06, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, [...]
Retrieve Medical Announces Newly Issued Patent for Enhanced Problem List Management in EHR Systems
06/06/2024
BEDMINSTER, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC Pink: RMHI) is proud to announce the granting of a new patent that revolutionizes the management of problem lists within [...]
MangoRx Receives Notice of Acceptance for Patent Application in Australia for Respiratory Illness and Preventive Care Technology
06/06/2024
Dallas, Texas, June 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“ MangoRx ” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness [...]
Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease
06/06/2024
Company expects to lock database in June and remains on track to report key outcomes later in July. Pepinemab targets astrocyte reactivity and neuroinflammation, believed to be key drivers of neurodegeneration. [...]
CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath
06/06/2024
BERKELEY HEIGHTS, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and [...]
Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
06/06/2024
NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]
Anthos Therapeutics Announces ~84% of Eligible Patients Have Transitioned to Abelacimab in the AZALEA-TIMI 71 Extension Study of Atrial Fibrillation Patients at a Moderate-to-High Risk of Stroke
06/06/2024
75% of patients in the rivaroxaban arm voluntarily switched from the once-daily oral anticoagulant to once-monthly abelacimab Landmark AZALEA-TIMI 71 Study previously stopped early due to an overwhelming benefit [...]
RapidAI Wins 2024 MedTech Breakthrough Award For “Best Care Coordination Platform”
06/06/2024
Prestigious International Annual Awards Program Recognizes the Breakthrough Innovation of the RapidAI Clinical Platform LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- MedTech Breakthrough , an independent market [...]
Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™
06/06/2024
SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the [...]
ViaDerma Provides Highlights of Quarterly Financial Report
06/06/2024
The Company is expanding its staff by hiring new full-time employees LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM ) is pleased to announce that on May 13, 2024, the Company released its [...]
Madrigal Pharmaceuticals Announces New Data from the Phase 3 MAESTRO-NASH Study of Rezdiffra™ (resmetirom) Presented at the EASL Congress
06/06/2024
Late-breaking AI-based analysis of MAESTRO-NASH biopsy data demonstrates Rezdiffra improved key fibrotic features that are predictive of progression to decompensated cirrhosis Noninvasive test data through three years [...]
Helio Genomics to Host In-Person & Virtual KOL Event in New York to Review Results from CLiMB Pivotal Trial Presented at EASL Congress 2024 on June 17, 2024
06/06/2024
IRVINE, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Helio Genomics (“Helio” or “the Company”), an AI-driven healthcare company specializing in diagnostics technology and test development for cancer detection, today [...]

Pages